RIO DE JANEIRO, BRAZIL – A drug used at parties is showing evidence of legitimacy: hallucinogenic mushrooms have overcome the first obstacle to conducting the tests needed before the drug can be used as treatment against depression.
Psilocybin, the active ingredient in mushrooms, was considered safe and well-tolerated when administered to healthy volunteers, in a study conducted by researchers at King’s College London.
Obviously, the test left the individuals “high”.
Companies and researchers have investigated the medical and commercial potential of recreational drugs such as marijuana.
Source: Infomoney
This article was produced by The Rio Times’ automated AI newsroom. Editorial responsibility: Matthias Camenzind, Publisher and Editor-in-Chief. The Rio Times also runs Ask Rio Times, which answers from 100,000+ of our own articles, the daily Latin America Power Map, and prediction-market odds on elections and markets.. How we use AI · Report an error
Read More from The Rio Times